Evidence map›Paper›PMID 39167187›Full record

ArticleActa neuropathologica2024

FGFR1 wild-type rosette-forming glioneuronal tumours.

Mégane Le Quang, Aude Trinquet, Aurore Siegfried, Amaury de Barros, Luc Bauchet, Sam Ng, Vincent Jecko, Guillaume Chotard, Morgan Ollivier, Gilles Adam and 6 more

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mégane Le QuangPathology Department, Bordeaux University Hospital, Bordeaux, France.
Aude TrinquetPathology Department, Montpellier University Hospital, Montpellier, France.
Aurore SiegfriedPathology Department, Toulouse University Hospital, Toulouse, France.
Amaury de BarrosNeurosurgery Department, Toulouse University Hospital, Toulouse, France.
Luc BauchetMontpellier Institute for Neuroscience (IGF), INSERM U1191, Montpellier University Hospital, Montpellier, France.
Sam NgMontpellier Institute for Neuroscience (IGF), INSERM U1191, Montpellier University Hospital, Montpellier, France.
Vincent JeckoNeurosurgery Department, Bordeaux University Hospital, Bordeaux, France.
Guillaume ChotardPathology Department, Bordeaux University Hospital, Bordeaux, France.
Morgan OllivierNeuroimaging Department, Bordeaux University Hospital, Bordeaux, France.
Gilles AdamNeuroimaging Department, Toulouse University Hospital, Toulouse, France.
Fabrice BonnevilleNeuroimaging Department, Toulouse University Hospital, Toulouse, France.
Julien Masliah-PlanchonGenetics Department & Oncopaediatry and Young Adults Department, Curie Institute, Paris, France.
Yvan NicaiseINSERM U1037, Toulouse Cancer Research Centre (CRCT), Toulouse, France.
Clémentine DecampsINSERM U1037, Toulouse Cancer Research Centre (CRCT), Toulouse, France.
Valérie RigauPathology Department, Montpellier University Hospital, Montpellier, France.
Emmanuelle Uro-CostePathology Department, Toulouse University Hospital, Toulouse, France. uro-coste.e@chu-toulouse.fr.ORCID 0000-0001-7300-5724

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsReceptor, Fibroblast Growth Factor, Type 1AdultFemaleHumansMaleFGFR1 protein, humanReceptor, Fibroblast Growth Factor, Type 1

Identifiers

PMID39167187
PMCPMC11339136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.